Navigation Links
Silence Therapeutics and InteRNA Technologies Sign Collaboration to Develop Novel microRNA Therapeutics
Date:9/11/2011

ultiple proprietary siRNA delivery technology platforms including AtuPLEX™ and DACC. AtuPLEX enables the broad functional delivery of siRNA molecules to targeted diseased tissues and cells, while increasing their bioavailability and intracellular uptake. The DACC delivery system allows functional delivery of siRNA molecules selectively to the lung endothelium with a long duration of target mRNA and protein knock-down. Additionally, the Company has a platform of novel siRNA molecules based around its AtuRNAi chemical modification technology, which provides a number of advantages over conventional siRNA molecules. Silence's unique RNAi assets also include structural features for RNAi molecules and specific design rules for increased potency and reduced off-target effects of siRNA sequences.

The Company's lead internal drug candidate is Atu027, a liposomal formulation in clinical development for systemic cancer indications and one of the most clinically advanced RNAi therapeutic candidates in the area of oncology. Atu027 incorporates two of the Company's technologies, AtuRNAi and AtuPLEX™. Silence is currently conducting an open-label, single-centre, dose-escalation Phase I study with Atu027 in patients with advanced solid tumors involving single, as well as repeated, intravenous administration. Encouraging interim data were presented at the American Society of Clinical Oncology Annual Meeting in June 2011. The study is expected to be completed in the second half of 2011.

The Company's RNAi therapeutic platform has received key validation through multiple partnerships with pharmaceutical companies including AstraZeneca, Dainippon Sumitomo, Pfizer/Quark, and Novartis/Quark. Silence is actively pursuing the establishment of additional partnerships. Silence Therapeutics has operations in both Berlin and London.

About InteRNA Technologies B.V. (http://www.interna-technologies.com'/>"/>

SOURCE Silence Therapeutics Plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology
2. Silence Therapeutics Phase I Atu027 Data Accepted for Presentation at the American Society of Clinical Oncology 2011 Annual Meeting
3. Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials
4. Silence Therapeutics Provides Year-end Update
5. Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics
6. Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
7. Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
8. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
9. Silence Therapeutics Announces Board Changes
10. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
11. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , July 3, 2015  Obsidian HDS, the developer ... online service for the management of data on pharmaceutical ... that PharmaShine now includes the 2014 Open Payments General ... Services on June 30. The data disclosed on Open ... between industry and providers totaling $6.49 billion and is ...
(Date:7/2/2015)... 3 juillet 2015 BGI a annoncé aujourd,hui ... de l,ADN situé à Hong Kong ... College of Pathologists  (Collège des pathologistes américains, ou ... Hong Kong constituent le premier laboratoire ... la certification du CAP en Chine, car il ...
(Date:7/2/2015)... -- ResMed Inc. (NYSE: RMD ) today announced that ... June 30, 2015 results on Thursday, July 30, 2015, after ... with ResMed,s results will be issued after 1:00 p.m. US ... discuss operating results and future outlook. The earnings ... Time and the live webcast of the call can be ...
Breaking Medicine Technology:New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2BGI obtient la certification du Collège des pathologistes américains (CAP) 2ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2
... (Nasdaq: ELGX ), developer of minimally invasive treatments ... of its third quarter 2010 financial results, which will take ... the market. Endologix will hold a conference call ... 2:30 p.m. PT to discuss the results. The dial-in numbers ...
... Reportlinker.com announces that a new market research ... Global Veterinary Vaccines Industry ... analyzes the worldwide markets for Veterinary Vaccines in ... Animal Vaccines (Canine Vaccines, & Feline Vaccines), and ...
Cached Medicine Technology:Endologix to Report Third Quarter 2010 Financial Results on October 27, 2010 2Reportlinker Adds Global Veterinary Vaccines Industry 2Reportlinker Adds Global Veterinary Vaccines Industry 3Reportlinker Adds Global Veterinary Vaccines Industry 4Reportlinker Adds Global Veterinary Vaccines Industry 5Reportlinker Adds Global Veterinary Vaccines Industry 6Reportlinker Adds Global Veterinary Vaccines Industry 7Reportlinker Adds Global Veterinary Vaccines Industry 8Reportlinker Adds Global Veterinary Vaccines Industry 9Reportlinker Adds Global Veterinary Vaccines Industry 10Reportlinker Adds Global Veterinary Vaccines Industry 11Reportlinker Adds Global Veterinary Vaccines Industry 12Reportlinker Adds Global Veterinary Vaccines Industry 13Reportlinker Adds Global Veterinary Vaccines Industry 14Reportlinker Adds Global Veterinary Vaccines Industry 15Reportlinker Adds Global Veterinary Vaccines Industry 16Reportlinker Adds Global Veterinary Vaccines Industry 17Reportlinker Adds Global Veterinary Vaccines Industry 18Reportlinker Adds Global Veterinary Vaccines Industry 19Reportlinker Adds Global Veterinary Vaccines Industry 20Reportlinker Adds Global Veterinary Vaccines Industry 21Reportlinker Adds Global Veterinary Vaccines Industry 22Reportlinker Adds Global Veterinary Vaccines Industry 23
(Date:7/3/2015)... ... July 03, 2015 , ... First Choice Emergency Room , ... N. Manzanares, MD as the new Medical Director of its Frisco facility. , “We ... our Frisco facility,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to ... the first sweetFrog store located in Mississippi. The premium frozen yogurt chain was listed ... The store, located at 104 Railroad Avenue, New Albany, MS 38652, will have a ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... structure retrofit project at the University of Minnesota, they knew it would save ... would also be an award-winning choice: the total energy savings after installation was ...
(Date:7/2/2015)... ... ... As Americans celebrate the Fourth of July outdoors this weekend, local physicians are warning ... UV Safety Month, and physicians at American Family Care and AFC Doctors Express urgent ... most skin cancers can be found early with regular skin exams. Physicians can give ...
(Date:7/2/2015)... ... 2015 , ... ActiveBunch.com recently launched as a social network created for people ... a lifestyle community, Active Bunch allows users to connect with like-minded fitness enthusiasts from ... discussions or group events. , The spokesperson for Active Bunch explained the idea ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4Health News:ActiveBunch.com Launches as a Social Community for People with Active Lifestyles 2
... Feb. 29 Dialysis Corporation,of America (Nasdaq: DCAI ... quarter and full year financial results on March 13, ... also begin hosting conference calls,in conjunction with its quarterly ... he held the following morning, March 14,2008 at 10:00 ...
... TOKYO, JAPAN & PRINCETON, NEW JERSEY, FEBRUARY 29 -- ... BMY) announced today that the U.S. Food and Drug ... ABILIFY (aripiprazole) for the acute treatment of manic and ... without psychotic features in pediatric patients (10 to 17 ...
... in the Mojave Desert, Calif., has found that soils under ... type of salt, close to the surface. Vulnerable to erosion ... this vast source of nitrate could contaminate surface and groundwaters, ... in the March issue of Geology . , Desert ...
... a new partnership to publish the International Journal of ... 1997) on Springers online information platform SpringerLink. The ... published by Carden Jennings. , Since 1937 the International ... the Japanese Society of Hematology (JSH), has published leading ...
... Feb. 29 Children,s Healthcare of Atlanta, one,of ... a,landmark investment in the future of pediatric research ... million of the Children,s,endowment toward pediatric research., ... be,invested in pediatric research," said James E. Tally, ...
... adults of McGuire Memorial, PITTSBURGH, Feb. 29 ... will hold its annual dinner and gala event,A Special ... at the,Pittsburgh Westin Convention Center Hotel beginning at 6 ... broadcast,journalist, will serve as Master of Ceremonies. The Most ...
Cached Medicine News:Health News:Dialysis Corporation of America Announces Fiscal Year 2007 Earnings Release Date 2Health News:ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old 2Health News:ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old 3Health News:ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old 4Health News:Large source of nitrate, a potential water contaminant, found in near-surface desert soils 2Health News:Large source of nitrate, a potential water contaminant, found in near-surface desert soils 3Health News:Springer to publish International Journal of Hematology 2Health News:Children's Healthcare of Atlanta Announces Major Investment in Pediatric Research as Part of 10-Year Vision 2Health News:Children's Healthcare of Atlanta Announces Major Investment in Pediatric Research as Part of 10-Year Vision 3Health News:McGuire Memorial to Host Annual Gala and Auction Event 2
... 1000 Power Instrument System is a ... versatility and convenience with modular and ... without hand throttle, for use with ... pedal. Accepts all 1000 and 2000 ...
... Brasseler USA™ Battery Packs contain rechargeable nickel ... a great impact upon battery life. Strict ... Any deviation from these recommendations will shorten ... to heat. Any exposure of the Battery ...
... USA™ offers a comprehensive line of high ... one piece construction method that minimizes breakage. ... and polished to create the sharpest edge ... surgical procedure., ,Our high speed cutters ...
Pneumatic High-speed Drill, 90k Rpm, With Microaire Hose Connector....
Medicine Products: